The expression of the tumor suppressor gene superoxide dismutase3 (SOD3) is downregulated in breast cancer; therefore, SOD3 expression levels are inversely correlated to its promoter CpG methylation, which is significantly associated with poor outcome patients [34]. Here, SOD3 is linked to breast carcinoma.